Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001193125-20-071623
Filing Date
2020-03-12
Accepted
2020-03-12 16:28:06
Documents
3
Group Members
BCIP LIFE SCIENCES ASSOCIATES, LP

Document Format Files

Seq Description Document Type Size
1 SC 13D/A d898924dsc13da.htm SC 13D/A 59137
2 EX-99.D d898924dex99d.htm EX-99.D 121896
3 EX-99.E d898924dex99e.htm EX-99.E 307362
  Complete submission text file 0001193125-20-071623.txt   489929
Mailing Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710
Business Address 2929 SEVENTH STREET SUITE 100 BERKELEY CA 94710 5108485100
DYNAVAX TECHNOLOGIES CORP (Subject) CIK: 0001029142 (see all company filings)

EIN.: 330728374 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-80035 | Film No.: 20709169
SIC: 2834 Pharmaceutical Preparations

Mailing Address 200 CLARENDON STREET BOSTON MA 02116
Business Address 200 CLARENDON STREET BOSTON MA 02116 617-516-2000
Bain Capital Life Sciences Fund, L.P. (Filed by) CIK: 0001687968 (see all company filings)

EIN.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: SC 13D/A